MedTrace Logo

Palliative Pancreatic Duct Stenting in Patients With Inoperable Pancreatic Cancer

NCT03069664 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2022-08-16

No results posted yet for this study

Summary

Patients with pancreatic cancer often suffer from chronic abdominal pain, weight loss and decreased quality of life. The patients also often need pancreatic enzyme supplements. In this prospective study the aim is to see whether patients undergoing palliative pancreatic duct drainage will experience less chronic abdominal pain and a higher quality of life than patients with the same diagnosis without the procedure. The study also investigates whether the nutritional state of the patients with palliative stents remains better than in the control group.

Conditions

Interventions

PROCEDURE

ERCP

endoscopic retrograde cholangiopancreatography

DEVICE

Covered Self-expandable Metal Stent

Pancreatic duct stent

Sponsors & Collaborators

  • Helsinki University Central Hospital

    lead OTHER

Principal Investigators

  • Leena Kylänpää, MD, PhD · Helsinki UniversityHospital

  • Sini M Vehviläinen, MD · Helsinki University Central Hospital

  • Hanna Seppänen, MD, PhD · Helsinki University Central Hospital

  • Marianne Udd, MD, PhD · Helsinki University Central Hospital

  • Outi Lindström, MD, PhD · Helsinki University Central Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-17
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03069664 on ClinicalTrials.gov